H.C. Wainwright Sticks to Its Buy Rating for Elicio Therapeutics (ELTX)
I'm PortAI, I can summarize articles.
H.C. Wainwright's Robert Burns reiterated a Buy rating for Elicio Therapeutics (ELTX) with a $13.00 price target. Burns, a 2-star analyst with a 0.1% average return, focuses on the Healthcare sector. JonesTrading also maintained a Buy rating with an $18.00 target. The report highlights analyst insights and investment ratings for ELTX.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments